Martin Goldstein Net Worth

Martin Goldstein biography

Dr. Martin Goldstein, M.D., is Director of NanoVibronix, Inc. Dr. Goldstein has been a practicing urologist since 2000, with particular expertise in the management of stone disease. Dr. Goldstein is also an entrepreneur in the medical field. He is an executive director of New Jersey Urology, the largest urology practice group in New Jersey, which he helped develop, and a co-founder and member of the executive board of Metropolitan Surgery Center, a large multispecialty ambulatory surgery center. Dr. Goldstein is co-founder and co-inventor of a medical device company that has received a Binational Industrial Research and Development (BIRD) Foundation grant and he is also co-founder of an IT company that provides advanced inter-physician communication solutions. Dr. Goldstein brings to our board his medical practice expertise. He is expected to make a valuable contribution in connection with marketing and facilitating the acceptance of our product offerings within the medical community. We also expect that he will provide assistance with the U.S. Food and Drug Administration regulatory approval process of our products, particularly our urology offerings.

How old is Martin Goldstein?

Martin Goldstein is 46, he's been the Director of NanoVibronix Inc since 2015. There are 8 older and 1 younger executives at NanoVibronix Inc. The oldest executive at NanoVibronix Inc is William Stern, 72, who is the President.

What's Martin Goldstein's mailing address?

Martin's mailing address filed with the SEC is C/O NANOVIBRONIX, INC., 525 EXECUTIVE BOULEVARD, ELMSFORD, NY, 10523.

Insiders trading at NanoVibronix Inc

Over the last 8 years, insiders at NanoVibronix Inc have traded over 0$ worth of NanoVibronix Inc stock and bought 131,000 units worth 98,060$ . The most active insiders traders include Christopher M Fashek、Thomas Mika、Harold Jacob. On average, NanoVibronix Inc executives and independent directors trade stock every 190 days with the average trade being worth of 14,078$. The most recent stock trade was executed by Thomas Mika on 5 January 2023, trading 50,000 units of NAOV stock currently worth 12,500$.

What does NanoVibronix Inc do?

nanovibronix inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology. the company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. this unique development may be utilized for a variety of medical requiring low cost therapeutic ultrasound applications. the company's patch based product diagnosis, painshield®, carries an fda clearance. nanovibronix catheter based products include the cathbottm . nanovibronix inc. is located in elmsford, ny. its subsidiary, nanovibronix ltd. is located in nesher, israel.

NanoVibronix Inc executives and stock owners

NanoVibronix Inc executives and other stock owners filed with the SEC include:

• Brian M. Murphy,
  CEO & Director
• Stephen R. Brown CPA, CPA,
  CFO & Accounting Officer
• Harold Jacob,
  Chief Medical Officer, Director
• Stephen Brown,
  Chief Financial Officer
• Thomas Mika,
  Independent Director
• Michael Ferguson,
  Independent Director
• Martin Goldstein,
  Director
• Brian Murphy,
  Chief Executive Officer, Director
• William Stern,
  President
• Christopher Fashek,
  Chairman of the Board
• Dr. Harold Jacob M.D.,
  Chief Medical Officer & Director
• Lindsey Harrison,
  VP of Sales
• Amir Rippel,
  VP of Marketing
• Ira A Greenstein,
  Director
• Maria Schroeder,
  Director
• Aurora Cassirer,
  Director